161 related articles for article (PubMed ID: 16533787)
1. Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.
Adams GP; Tai MS; McCartney JE; Marks JD; Stafford WF; Houston LL; Huston JS; Weiner LM
Clin Cancer Res; 2006 Mar; 12(5):1599-605. PubMed ID: 16533787
[TBL] [Abstract][Full Text] [Related]
2. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv.
Adams GP; McCartney JE; Tai MS; Oppermann H; Huston JS; Stafford WF; Bookman MA; Fand I; Houston LL; Weiner LM
Cancer Res; 1993 Sep; 53(17):4026-34. PubMed ID: 7689421
[TBL] [Abstract][Full Text] [Related]
3. Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration.
Adams GP; McCartney JE; Wolf EJ; Eisenberg J; Tai MS; Huston JS; Stafford WF; Bookman MA; Houston LL; Weiner LM
Cancer Immunol Immunother; 1995 May; 40(5):299-306. PubMed ID: 7600561
[TBL] [Abstract][Full Text] [Related]
4. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA
Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692
[TBL] [Abstract][Full Text] [Related]
5. Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimers.
Tai MS; McCartney JE; Adams GP; Jin D; Hudziak RM; Oppermann H; Laminet AA; Bookman MA; Wolf EJ; Liu S
Cancer Res; 1995 Dec; 55(23 Suppl):5983s-5989s. PubMed ID: 7493381
[TBL] [Abstract][Full Text] [Related]
6. Tumor targeting in a murine tumor xenograft model with the (sFv')2 divalent form of anti-c-erbB-2 single-chain Fv.
Huston JS; Adams GP; McCartney JE; Tai MS; Hudziak RM; Oppermann H; Stafford WF; Liu S; Fand I; Apell G
Cell Biophys; 1994; 24-25():267-78. PubMed ID: 7736532
[TBL] [Abstract][Full Text] [Related]
7. Enhanced tumor specificity of 741F8-1 (sFv')2, an anti-c-erbB-2 single-chain Fv dimer, mediated by stable radioiodine conjugation.
Adams GP; McCartney JE; Wolf EJ; Eisenberg J; Huston JS; Bookman MA; Moldofsky P; Stafford WF; Houston LL; Weiner LM
J Nucl Med; 1995 Dec; 36(12):2276-81. PubMed ID: 8523119
[TBL] [Abstract][Full Text] [Related]
8. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
George AJ; Jamar F; Tai MS; Heelan BT; Adams GP; McCartney JE; Houston LL; Weiner LM; Oppermann H; Peters AM
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8358-62. PubMed ID: 7667295
[TBL] [Abstract][Full Text] [Related]
9. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.
Adams GP; Schier R; Marshall K; Wolf EJ; McCall AM; Marks JD; Weiner LM
Cancer Res; 1998 Feb; 58(3):485-90. PubMed ID: 9458094
[TBL] [Abstract][Full Text] [Related]
10. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
Nielsen UB; Adams GP; Weiner LM; Marks JD
Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
[TBL] [Abstract][Full Text] [Related]
11. Single-chain Fv radioimmunotargeting.
Huston JS; George AJ; Adams GP; Stafford WF; Jamar F; Tai MS; McCartney JE; Oppermann H; Heelan BT; Peters AM; Houston LL; Bookman MA; Wolf EJ; Weiner LM
Q J Nucl Med; 1996 Sep; 40(3):320-33. PubMed ID: 8961808
[TBL] [Abstract][Full Text] [Related]
12. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
Yokota T; Milenic DE; Whitlow M; Wood JF; Hubert SL; Schlom J
Cancer Res; 1993 Aug; 53(16):3776-83. PubMed ID: 8339291
[TBL] [Abstract][Full Text] [Related]
13. Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu.
Adams GP; Schier R; McCall AM; Crawford RS; Wolf EJ; Weiner LM; Marks JD
Br J Cancer; 1998 May; 77(9):1405-12. PubMed ID: 9652755
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library.
Schier R; Marks JD; Wolf EJ; Apell G; Wong C; McCartney JE; Bookman MA; Huston JS; Houston LL; Weiner LM
Immunotechnology; 1995 May; 1(1):73-81. PubMed ID: 9373335
[TBL] [Abstract][Full Text] [Related]
15. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
Adams GP; Schier R; McCall AM; Simmons HH; Horak EM; Alpaugh RK; Marks JD; Weiner LM
Cancer Res; 2001 Jun; 61(12):4750-5. PubMed ID: 11406547
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
17. Medical applications of single-chain antibodies.
Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
[TBL] [Abstract][Full Text] [Related]
19. On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.
Orlova A; Wållberg H; Stone-Elander S; Tolmachev V
J Nucl Med; 2009 Mar; 50(3):417-25. PubMed ID: 19223403
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors.
Orlova A; Rosik D; Sandström M; Lundqvist H; Einarsson L; Tolmachev V
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):314-23. PubMed ID: 17464277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
